Malattie rare – 6-9 GIUGNO 2018, Magazzini del Cotone (Genova): XVIII Congresso Nazionale Associazione Italiana di Miologia (AIM)

From Basic Muscle Science to Translational Myology

Sede Congressuale / Congress Venue

Porto Antico di Genova – Magazzini del Cotone 

Centro Congressi, SALA MAESTRALE, Via Magazzini del Cotone – modulo 10

Il Porto Antico è l’area del centro storico di Genova che si affaccia sul mare, facilmente raggiungibile con mezzi pubblici e privati.

www.centrocongressigenova.it

Informazioni generali

Sito web del Congresso: www.fclassevents.com/it/aim2018/

Iscrizioni:

E’ possibile iscriversi online entro il 23 Maggio 2018, con pagamento tramite bonifico bancario o con carta di credito. Dopo il 23 Maggio sarà possibile iscriversi solo in sede congressuale, con pagamento in contanti o con carta di credito (Visa o Mastercard, no American Express).

L’evento è in fase di accreditamento ECM.

MERCOLEDÌ 6 GIUGNO

13.00 Registration

14.00 Congress Welcome (President of AIM; President of SIN)

14.30 WORKSHOP 1 “Basic Muscle Science” – Chairperson Claudio Bruno, Massimo Zeviani

• The Transcription Factor Nfix in muscle development and muscular dystrophies – Graziella Messina (Milano);
• The pathogenetic mechanisms of muscular dystrophy – Antonio Musarò (Roma);
• Muscle contraction and metabolic adaptation: molecular mechanisms – Marco Sandri (Padova);
• Three-dimensional Human iPS Cell-derived Artificial Skeletal Muscles for Disease Modelling and Tissue Engineering – Francesco Saverio Tedesto (London, UK);

16.00 LECTURE 1 a tribute to Professor Giovanni Nigro – Introduction: Corrado Angelini

• Contribution of the Naples School to the knowledge of myocardial involvement in Neuromuscular Diseases – Luisa Politano (Napoli).

16.30 AIM NETWORKS –  Introduction and on going Networks Gabriele Siciliano (Pisa)

• FSHD – Rossela Tupler, Modena;
• Mitochondrial Myopathies – Michelangelo Mancuso, Pisa;
• Muscle Glycogenosis – Antonio Toscano, Messina
• Laminopathies – Giovanna Lattanzi, Bologna

Proposed future Networks – Maurizio Moggio, Milano

• Muscle Channelopaties – Valeria Sansone, Milano
• Congenital Muscular Dystrophies – Adele D’Amico, Roma
• Lipid Myopathies – Lorenzo Maggi, Milano
• Connetive tissue muscle disorders – Angela Berardinelli, Pavia
• Myasthenic Syndromes – Carmelo Rodolico, Messina
• Distal myopathies – Giorgio Tasca, Roma
• Infiammatory Myopathies – Massimiliano Mirabella, Roma

17.30 The Ern-NMD – Work in progress 2017-2018 Teresinha Evangelista, Newcastle, UK

18.00 SIMPOSYOUM 1 – New perpectives on early diagnosis in DMD

Moderator: Angela Berardinelli

• How to accelerate early diagnosis – Alessandra Ferlini, Ferrara
• Territorial network to support DMD patients – Tiziana Mongini, Torino
• Therapeutical approach to nonsense mutations – Adele D’Amico, Roma

19.30 WELCOME COCKTAIL

GIOVEDÌ 7 GIUGNO

7.30 Breakfast Seminar 1: Nutrition in NMD – Moderator: Antonio Di Muzio;

• Nutrition in the healthy population – Francesco Francini (Padova);
• From evidence to dietary recommendations in NMD – Antonella Pini (Bologna);
• Body composition and energy expenditure in SMA patients – Simona Bertoli (Milano);

8.30 Oral Presentation 1: Congenital Myopathies – Chairpersons: Roberto Massa, Marina Mora

• Role of muscle biopsy  study in the diagnosis of floppy infants – C. Fiorillo, F. DAzzi, P. Broda, C. Romano, S. Savasta, R. Falsaperla, A. Donati, M. Pedemonte, E. GAzzero, C. Bruno, C. Minetti (Genova; Catania; Pavia; Firenze; Berlino, DE);
• Redefining morphological spectrum of RYR1 recessive myopathies – M. Garibaldi, J. Rendu, J. Brocard, E. Lacene, G. Brochier, M. Bewin, Labasse, F. Levy-Borsato, A. Madelaine, E. Malfatti, J. Bevilacqua, F. Lubieniecki, S. Monges, AL. Taratuto, I. Marty, G. Antonini, NB Romero (Parts, FR, Roma, Grenoble, FR; Santiago; Chile, Buenos Aires, Argentina;
• Novel phenotypes of congenital myopapthis: importance of the ultrastructural eletron miscroscopy study – E. Malfatti, J. Bohm, X. Lornage, V. Chartner, G. Brochter, A. Madelaine, C. Labasse, M. Fardeau; J. Laporte, N. B. Romero (Parigi, FR, Illkirch, FR, Garches; FR;
• WEA analysis identified MSTO1 as novel disease gene in two families with 3 patients presenting a complex phenotype characterized by congenital myopathy and ataxia – M. Neri, A. Nasca, C. Scotton, I. Zaharieva, R. Selvatici, O. Thor Magnusson, A. Gal, G. Kiriko, D. Weaver, R. Rossi, A. Armaroli, M. Pane, M. Zeviani, F. Muntoni, D. Ghezzi, A. Ferlini (Ferrara; Milano; London; UK; Iceland; Philadelphia, USA; Roma; Firenze; Cambridge, UK);
• Clinical characterization of an Italian cohort of patients with early-onset LMNA-related myopaty – G. Ricci, C. Fiorillo, A. D’Amico, G. Astrea, C. Rodolico, L. Vercelli, T. Mongini, C. Semplicini, E. Pegoraro, L. Politano, E. Mercuri, S. Benedetti, A. Berardinelli, S. Previtali, N. Carboni, G. Marrosu, E. Bertini, G. Siciliano, G. Lattanzi, L. Maggi, Italian Network for Laminopathies (Pisa; Genova, Messina; Torino; Padova; Napoli; Roma; Milano; Pavia; Nuoro; Cagliari; Bologna).

9.30 WORKSHOP 2 “The floppy infant; diagnosis and management” – Chairperson: Enrico Bertini, Carlo Minetti

• Differential diagnosis – Eugenio Mercuri (Roma);
• Invasive supportive measures: when? – Marina Pedemonte (Genova);
• Early onset peripheral neuropathies: the dark side of the moon – Isabella Moroni (Milano);
• Myasthenic syndrome and channelopathies – Carmelo Rodolico (Messina);

11.00 Coffee break

11.20 MITO – LECTURE 2: Introduction: Salvatore DiMAuro

• A New approach to the Treatment of Mitochondrial Disorders – Michio Hirano (New York, USA);
• Rapamycin rescue a mitochondrial myopathy model – Massimo Zeviani (Cambridge, UK).

12.20 SYMPOSIUM 2: The clinical landscape for SMA in a new therapeutic era – Moderators: Claudio Bruno, Eugenio Mercuri;

• SMA natural history changes in light of new clinical data – Marica Pane (Roma);
• SMA adult patients: first experiences – Giacomo P. Comi (Milano);
• Discussant: Eugenio Mercuri (Roma); Claudio Bruno (Genova);

13.20 Lunch

14.20 ROUND TABLE

Role of reabilitation in Pompe Disease – Giovanni Iolascon (Napoli), Tiziana Mongini (Torino); Gabriele Siciliano (Pisa), Antonio Toscano (Messina)

15.00 Aig Kit: digital approach in doctor-patient relationship in Pompe disease – Sigrid Baldanzi (Pisa) e Giulia Ricci (Pisa);

15.20 POSTER SESSION -1 (Sessione non accreditata ECM)

P-1-1 BASIC SCIENCE – Chairpersons: Luca Bello, Chiara Fiorillo;

P-1-2 CHANNELOPATHIES AND MYOTHONIC DISORDERS – Chairpersons. Carmelo Rodolico, Liliana Vercelli;

P-1-3 DMD and BMD – Chairpersons: Luca Doglio, Federica Ricci;

P-1-4 FSHD / Infiammatory Myopathies – Chairpersons: Rita Barresi, Lucia Ruggiero;

P-1-5 LGMD – Chairpersons: Francesca Magri, Gianluca Vita

16.20 Oral Presentations 2: Metabolic Myopathies

Chairpersons: Maria Alice Donati, Serenella Servidei

• Lectin staining of skin biopsy is a convenient and sensitive tool to diagnose GNE myopathy – R. Barresi, Y. Parkhurst, O. Pogoryelova, G. Eglon, r. Wake, V. Straub (Newcastle upon Tyne, UK);
• Myotonic dystrophy in Abruzzo – A. Di Muzio, R. Telese, R. Carlino, F. Barbone, M. Vitale, E. Rastelli, F. Lozzi, R. Massa (Chieti; Roma);
• Vacuolar lipid storage myopathies responsive to Riboflavin – A. Lupica, O. Musumeci, C. Rodolico, T. Brizzi, A. Ciranni, R. Arrigo, S. Volta, G. Vita, A. Toscano (Messina);
• Dietary treatment for McArdle’s disease: real promise or illusion? The rational for a multicenter RCT – A. Martinuzzi, M. Vavla, C. Stefan, E. Trevisi, G. Siciliano, G. Ricci, A. Toscano, O. Musumeci (Polo Regionale Veneto; Pisa; Messina);
• Ultrasound for assesment of diaphragm function in late-onset Pompe disease – O. Musumeci, P. Ruggeri, L. Lo Monaco, M. Gaeta, R. Arrigo, S.G. Caramori, A. Toscano (Messina);

17.20 Oral Presentations 3 – Therapies 1 – Chairpersons: Giacomo Comi, Rocco Liguori

• A retrospecitve study of respiratory function in the Italian Duchenne muscular dystrophy Network – l. Bello, M. Villa, S. Gandossini, G. D’Angelo, F. MAgri, G.P. Comi, M.Pedemonte, P. Tacchetti, V. Lanzillotta, C. Bruno, A. D’Amico, E. Bertini, G. Astrea, L. Politano, G. Baranello, E. Albamonte, E. De Mattia, F. Rao, V. Sansone, S. Previtali, S. Messina. G.L. Vita, A. Berardinelli, T. Mongini, M. Pane, E. Mercuri, A. Vianello, E. Pegoraro (Padova; Bosisio Parini; Milano; Genova; Roma; Napoli; Messina; Pavia; Torino);
• Pulmonary Function in Patients With Advanced Duchenne Muscular Distrophy: Eteplirsen-Treated Patients Compared With Multiple Natural History Cohorts – H. Gordish-Dressman, E. Henricson, N. Khan, L. Han, A. Dugar, C.M. McDonald, CINRG DNHS Investigators (Washington DC, USA; Cambridge, MA, USA);
• Rituximab for immunosoppresant resistant inflammatory myopathies: a single center case series and literature review – M. Lucchini, C. De Fino, M. Monforte, Ga Primiano, E. Ricci, S. Servidei, M. Mirabella (Roma);
• The Becker Muscular Dystrophy color in the Givinostat trial: clinical characterization and functional measures – F. Magri, D. Velardo, A. Govoni, C. Cinnante, L. Peverelli, S. Cazzaniga, L. Bello, R. Brusa, C. Semplicini, M.G. D’Angelo, S. Gandossini, M. Filosto, V. Sansone, S. Previtali, E. Pegoraro, S.Corti, M. Moggio, N. Bresolin, P. Bettica, G.P. Comi (Milano; Padova; Bosisio Parini; Brescia);
• Golodirsen Induces Exon Skipping Leading to Sarcolemmal Dystrophin Expression in Patient With Genetic Mutations Amenable to Exon 53 Skipping –  E. Mercuri, D.E. Franck, L. Servais, V. Straub, J. Morgan, J. Domingos, F. Schnell, G. Dickson, L. Popplewell, A. Seferian, M. Monforte, M. Guglieri, F. Muntoni, the SKIP-NMD Study Group (Roma; Cambridge, MA, USA; Paris; FR; Newcastle, UK; London, UK).

VENERDÌ 8 GIUGNO

7.30 Breakfast Seminar 2: New Perspectives in Molecular genetic technologies – Moderator Rossella Tupler

• New applied technologies in genomic field – Vincenzo Nigro (Napoli);
• Application of NGS techniques in neuromuscular disorders – Filippo M. Santorelli (Pisa);
• Opportunities and risks of genomic analysis in clinical practice – Federico Zara (Genova).

8.30 Oral Presentation 4 Basic Science – Chairpersons: Annalisa Botta, Vincenzo Nigro

• Proteomic analyses of FSHD muscular dystrophy by a combination of 2D-DIGE and MALDI ToF/ToF, ICPL and Label free Lc-MS/MS – D. Capitanio, E. Torretta, M. Moriggi, C. Fiorillo, L. Ruggiero, J. Baldacci, L. Santoro, FM Santorelli, C. Gelfi (Milano; Pisa; Napoli);
• TNPO3 and myogenesis in murine and human myoblasts – R. Costa, M.T. rodia, V. Papa, V. Pegoraro, L. Giaretta, R. Marozzo, C. Angelini, G. cenacchi (Bologna; Messina);
• RNAsew in urine-derived stem cells identified the expression of more than 300 neuromuscular gene trascripts – M.S. Falzarano, H. Osman, r. Sorri, R. Selvatici, M. Neri, F. Gualandi, M. Fang, Z. Lu, A. Grilli, S. Bicciato, A. Ferlini (Ferrara; Khartoum, Sudan; Shenzhen, China; Modena e Reggio Emilia; Londra, UK).

9.30 WORKSHOP 3 “Experimental therapies in Neuromuscular Disorders” – Chairpersons: Elena Pegoraro, Stefano Previtali

• SMA: from models to mechanism to therapy – Stefano Corti (Milano);
• Precision medicine in non-dystrophic myotonia – Jean Francoise Desaphy (Bari);
• Immunity I Muscular Dystrophies: Friend of Enemy? – Elisabetta Gazzerro (Berlin);
• Gene therapy for oculopharyngeal muscular dystrophy – Alberto Malerba (London).

11.00 Coffee Break

11.20 LECTURE 3 Introduction: Vincenzo Nigro

• Muscle-specific CRISPR/Cas9 dystrophin gene editing – Jeffrey S. Chamberlain (Seattle, USA)

12.00 Oral Presentation 5: Therapies 2 – Chairpersons: Sonia Messina, Paola Tonin

• Nutritional status in SMA type 1 over a 6 month follow-up in Nursinersen Expanded Access Program (EAP) – S. Messina, M.Sframeli, C. Bruno, M. Pane, V. Sansone, M. Catteruccia, C. Stancanelli, E. Albamonte, M. Pedemonte, A. D’Amico, E. Bertini, E. Mercuri, G. Vita on behalf of the Italian EAP working group (Messina; Genova; Roma; Milano);
• Development of Golodirsen by the SKIP-NMD Consortium and Design of a Phase ½ Trial of Golodirsen for the Treatment od DMD Amenable to Exon 52 Skipping – M. Monforte, D.E. Frank, E. Mercuri, L. Servais, V. Straub, J. Morgan, J. Domingos, F. Schnell, G. Dickson, L. Popplewell, A. Seferian, M. Gugliri, F. Muntoni, the SKIP-NMD Study Group (Cambridge, MA, USA; Newcastle upon Tyne, UK, London, UK);
• Effect of serum deprivation and WY14643 treatment on NLSDM fibroblasts – E.M. Pennisi, S. MIssaglia, F. Gragnani, M. Garibaldi, C. Angelini, M. Mora, D. Tavian (Milano; Venezia; Roma);
• Sport and Neuromuscular disease: psychosocial impact and physical benefits on a cohort of patients – C. Stancanelli, S. La Foresta, G.L. Vita, C. Faraone, G. Laganà, G. Vita (Messina);
• RG7916 distributes and increases SMN protein levels in both the central nervous system and peripheral organs – A. Poirier, M. Weetall, H. Ratni, K. Heining, N. Naryshkin, S. Paushkin, L. Mueller (Basel, Switzerland; South Plainfield, NJ, USA; New York, NY, USA);

13.00 Lunch

14.00 POSTER SESSION 2 (Sessione non accreditata ECM)

P2-1- Metabolic Myopathies – Chairpersons: Matteo Garibaldi; Claudio Semplicini;

P2-2 – Myastenic Syndromes – Chairpersons: Rosanna Cardani, Marina Grandis;

P2-3 – Congenital Myopathies – Chairpersons: Guya Astrea, Marina Pedemonte;

P2-4 – Mitochondrial Myopathies – Chairpersons: Daniele Orsucci, Olimpia Musumeci;

P2-6 – SMA – Chairpersons: Giovanni Baranello, Federica Trucco.

15.30 JOINT SESSION Associazione Italiana di Miologia (AIM), Société Francaise de Myologie (SFM) – Chairpersons: Gisèle Bonne, Gabriele Siciliano

Myotonic Dystrophy

• Translational research in myotonic dystrophy: recent advances and future challenges – Guillaume Bassez (Paris);
• Taking charge of myotonic dystrophy patients: from clinical practice to research – Valeria Sansone (Milano)

Pompe disease

• The French Pompe registry: molecular features of non-classical Pompe disease and study of benefit of long term ERT in adults – Pascal Laforêt (Garches);
• The Italian Registry for Muscle Glycogen: facts and perspectives – Antonio Toscano (Messina).

Laminopathies

• Mechanobiology defects in LMNA-related congenital muscular dystrophy – Catherine Coirault (Paris);
• Tendon contractures in Emery-Dreifuss Muscular Dystrophy: a major involvement of TGF beta 2 – Giovanna Lattanzi (Bologna).

17.30 Oral Presentations 6. Dystrophies (MD) – Chairpersons: Lorenzo Maggi, Andrea Martinuzzi

• Profiling brain functioning in Muscular Dystrophies (MD). Upgradind knowledge from on-going research – S. Baldanzi, G. Ricci, C. Simoncini, P. Cecchi, M. Cosottini, C. Angelini, G. Siciliano (Pisa; Venezia);
• Autosomal recessive bethlem myopathy: a clinical, gentic and functional study – F. Caria, M. Cescon, F. Gualandi, R. Rossi, P. Rimessi, S. Cotti Piccinelli, M. Marchesi, S. Gallo Cassarino, I. Gregorio, A. Ferlini, A. Padovani, P. Bonaldo, M. Filosto (Brescia; Padova; Ferrara);
• Use of muscle MRI to follow up patients with inflammatory idiopatic myopathies (IIM) – M. Colombo, D. Verlardo, A. Ambrosi, M. Scarlato, G.A. Ramirez, V. Canti, R. De Lorenzo, M. Cava1, R. Fazio, F. De Cobelli, P. Rovere Querini, S. C. Previtali (Milano);
• The JAIN Clinical Outcome Study in Dysferlinopathy – Cl. Semplicini, F. Smith, J. Marni, A.G. Mayhew, R. Fernandez-Torron, S. Spuler, J.W. Day, K.J. Jones, D.X.Bharucha-Goebel, E. Salort-Campana, A. Pestronk, M.C. Walter, C. Paradas, T. Stojkovic, M. Mori-Yoshimura, E. Bravver, J. Diaz-Manera, L. Bello, E. Pegoraro, J.R. Mendell, K. Bushby, V. Straub, The Jain COS Consortium (Padova; Newcastle upon Tyne, UK; Washington, DC, USA; Donostia-San Sebastian, Spain; Berlin, Germany; Stanford, CA, USA; Sydney, Australia; Washington, DC, USA; Bethesda, MD, USA; Marseille, France; St. Louis, MO, USA; Munich, Germany; Sevilla, Spain; Paris, France; Tokyo, Japan; Charlotte, NC, USA; Barcellona, Spain; Barcellona, Spain; Columbus, Ohio, USA);
• QUANTITATIVE MUSCLE ULTRASOUND ANALYSIS IN FSHD PATIENTS – F. Vanoli, A. Di Pasquale, G. Fragiotta, L. Fionda, L. Leonardi, M. Garibaldi, E. Bucci, S. Morino, A. Grossi, R. Tupler, G. Antonini (Roma, Modena e Reggio Emilia);

18.30 Assemblea Generale Soci AIM

CENA SOCIALE

SABATO 9 GIUGNO

8.30 MUSCLE CLUB Chairpersons: Costanza Lamperti, Monica Sciacco

• Clinical presentation of a congenital myopathies LGMD D2 new phenotype in an Hungarian family – C. Angelini, R. Marozzo, V. Pegoraro (Venezia);
• Unusual symptoms and pathology in a woman with myofibrillar myopathy – S. Bortolani, L. Vercelli, L. Chiadò-Piat, S. Boschi, T. Mongini (Torino);
• Exercise intolerance and myoglobinuria as presenting symptom of alpha-sarcoglycanopathy – M. Catteruccia, G. Primiano, F. Fattori, E. Bertini, S. Servidei, Adele D’Amico (Roma);
• Core and rod myopathy due to a novel mutation in BTB domain of KBTBD13 gene presenting as LGMD – M. Garibaldi, F.F. Fattori, C. Bortolotti, G. Brochier, C. Labasse, M. Verardo, E.M. Pennisi, A. Di Pasquale, E. Torchia, E. Bucci, S. Morino, E.S. Bertini, C. Paradas, N.B. Romero, G. Antonini (Roma; Modena e Reggio Emilia; Parigi, FR, Siviglia, ES);
• Late-onset axial myopathy (Bent spine syndrome): a case report – V. Montano, G. Ricci, F. Baldinotti, G. Alì, L. Chico, L. Calì Cassi, A. Barison, R. Costa, G. Cenacchi, M.A. Caligo, G. Siciliano (Pisa; Bologna);
• Filamin-C myopathy associated to brain and spinal cord abnormalities: expanding the clinical phenotype –  S.C. Previtali, M. Scarlato, P. Vezzulli, A. Ruggeri, D. Velardo, S. Benedetti, B. Colombo, L. Maggi, G. D’Angelo, M. Mora (Milano; Lecco).

9.30 WORKSHOP 4 “Idiopathic Inflammatory Myopathies” Chairpersons: Giovanni Antonini, Gianni Meola

• New classification – Margherita Milone (Rochester, USA);
• Infantile dermatomyositis – Angelo Ravelli (Genova);
• Adult Polimyositis – Massimiliano Filosto (Brescia);
• Necrotizing Autoimmune Myositis – Lorenzo Peverelli (Milano);

11.00 Coffee break

11.20 ROUND TABLE: Translational Medicine and social sanitary aspects in Neuromuscular Disorders – Moderators: Anna Ambrosini (Telethon), Carlo Minetti

Partecipants: CCMAN, Alleanza Neuromuscolare, UILDM, Famiglie SMA, Parent Project, Mitocon, ASAMSI, Altro Domani, A.I.D.M.E.D., M.i.A., I Malati Invisibili, Medici di Famiglia, Pediatri di Famiglia

Discussants:

• Camn: tra passato, presente  e futuro – Francesco Ieva (CAMN – Coordinamento Associazioni Malattie Neuromuscolari);
• La presa in carico globale tra aspetto sanitario e sociale –  Marco Rasconi (UILDM – Unione Italiana Lotta alla Distrofia Muscolare);
• Il supporto di Famiglie SMA alle EAP, ai centri per la somministrazione ed alle famiglie – Cristina Ponzanelli (Famiglie SMA – Atrofia Muscolare Spinale);
• La condivisione delle informazioni alle famiglie – Sara Capponi (Duchenne Parent Project);
• Sinergia tra comunità scientifica ed Associazioni. Ruolo nell’età di transizione –  Maria Letizia Solinas (ASAMSI);
• Attività associative per la qualità della vita – Cristina Rebagliati (Mitocon; Malattie Mitocondriali);
• Centri Esperti e rapporti con il territorio: le criticità della presa in carico mutidisciplinare quotidiana – Federico Arietti (Altro Domani);
• Lo Sportello Famiglia e le attività riabilitative – Andrea Rivano (UILDM – Sezione Genova);
• I malati orfani di diagnosi – Deborah Capanna (I Malati Invisibili);
• La gestione della cronicità nell’età evolutiva –  Giorgio Conforti (Pediatra di Famiglia);
• La continuità delle cure nelle malattie rare con disabilità complessa – Fabio Stellini (Medico di Famiglia.

Invited Talk
Introduction: Paolo Petralla

• Translational Medicine and Neuromuscular Disorders – Toni Andreu (Scientific European Infrastructure for Translational Medicine; EATRIS, Amsterdam, NED)
• Discussants: Angelo Schenone, Giuseppe Vita

13.20 Platform presentation of the best 3 Posters

13.30 Closing remarks

FOCACCIA FAREWELL LUNCH

Per conoscere le modalità di prenotazione, le indicazioni su come raggiungere il Congresso e per scaricare il Programma definitivo delle giornate in formato pdf: https://www.imalatiinvisibili.it/wp-content/uploads/2018/06/Programma_AIM_DEF.pdf

Fonte: AIM Associazione Italiana Miologia

Tratto da: http://www.miologia.org/index.php/152-congresso-aim-2018